Details

Last Funding Type

Series C

Last Funding Money Raised

$20M

Industries

Biotechnology,Genetics,Health Care,Health Diagnostics,Information Technology,Life Science,Personal Health

Founded date

Jan 1, 2014

Number Of Employee

101 - 250

Operating Status

Active

Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.